Senior Director Global Medical Affairs (Cardiovascular/Cardiometabolic Health)

Role Summary

The Senior/Executive Director, Global Medical Affairs in the Cardiovascular/Cardiometabolic Health Business Unit provides strategic medical planning and expert medical support across local/global activities related to launch, commercialization, regulatory interactions, pricing, reimbursement and access, and data dissemination. They serve as a scientific resource for study teams and ensure compliance with regulatory standards, GCPs, and Lilly policies. The role involves leading late-phase and marketed program activities, developing clinical/medical plans, and coordinating with global development teams to address patient and customer needs.

Responsibilities

• Support the planning of symposia, advisory board meetings, and other meetings with health care professionals.
• Support medical information in preparation and review of medical letters and other materials.
• Support training of medical personnel and health outcomes staff.
• Prepare or review scientific information in response to customer questions or media requests.
• Provide follow-up to information requested by health care professionals per global SOPs.
• Support data analysis and development of slide sets and publications (abstracts, posters, manuscripts).
• Establish and maintain collaborations with external scientific experts, thought leaders, and the medical community locally and internationally.
• Develop and maintain collaborations with professional societies.
• Support the design of customer research as a medical expert.
• Provide congress support (responding to questions at exhibits, oral/poster presentations, staff medical booth, meetings with thought leaders, customer events).
• Participate in data analyses, dissemination of scientific data, and preparation of final reports and publications.
• Participate in reporting of clinical trial data in Clinical Trial Registry activities.

Clinical Planning

• Collaborate with CRSs, regional clinical operations staff, statisticians, health outcomes, and investigators to develop protocols and data collection requirements.
• Identify and select investigators in conjunction with clinical teams.
• Ensure administrative requirements for study initiation and conduct are documented in line with GCPs and local laws.
• Assist in study start-up meetings and provide scientific training to investigators and site personnel.
• Serve as a resource to monitors, investigators and ethics boards to address questions during study conduct.
• Contribute to global alignment of Phase 3b/4 studies and, where applicable, Phase I/II studies.
• Understand and address the scientific information needs of investigators and personnel.
• Monitor patient safety and follow-up adverse events per corporate safety policies.

Regulatory Support Activities

• Be aware of current trends in clinical practice and access in relevant therapeutic areas.
• Critically read and evaluate medical literature and stay updated on developments relevant to the product.
• Provide scientific training of the clinical study team and act as a protocol expert.
• Explore opportunities for extramural scientific experiences and participate in medical congresses.

General Responsibilities

• Be an ambassador for patients and the Lilly Brand.
• Demonstrate deep understanding of cardiovascular pathophysiology, clinical management, medical affairs, data dissemination, and real-world evidence usage to support provider, patient, policy, and payer needs.

Qualifications

• Required: Medical Doctor or Doctor of Osteopathy. Must be board eligible or certified in the appropriate specialty/subspecialty or have completed the comparable level of post-medical school clinical training relevant to the country of hiring. US-trained physicians must have board eligibility or certification. Physicians trained outside the US who are not US board eligible or certified may be hired directly for employment in the US at the discretion of the Chief Medical Officer.
• Required: Non-US trained physicians must have completed education and training at a medical school meeting LCME requirements; refer to LCME list for recognized foreign medical schools.
• Required: Minimum 2 years of clinical experience in cardiovascular medicine.
• Preferred: Cardiology board-eligible or -certified.
• Preferred: Prior pharmaceutical industry experience in medical affairs or clinical development.
• Preferred: Knowledge of the drug development process.
• Preferred: Ability to balance scientific priorities with business priorities and to influence cross-functional teams.
• Preferred: Ability to engage in domestic and international travel as needed to support the business.
• Preferred: Strong leadership, communication, teamwork, negotiation skills, and fluency in English (verbal and written).

Skills

• In-depth understanding of cardiovascular pathophysiology and clinical management.
• Expertise in medical affairs planning for launch, data dissemination, and communication of early-phase and real-world evidence.
• Strong ability to engage with investigators, thought leaders, and external scientific communities.
• Effective project management and ability to coordinate cross-functional teams.
• Excellent written and verbal communication skills in English.

Additional Requirements

• Ability to travel domestically and internationally as required to support business objectives.